About Taiko Pharmaceutical
Taiko Pharmaceutical is a publicly listed company based in Osaka (Japan) founded in 1946. Pharmaceutical drugs are manufactured by Taiko Pharmaceutical in Japan. The company has 214 employees. Its chief executive, as recorded, is Takashi Shibata. Its website seirogan.co.jp draws about 199 thousand monthly visits. Taiko Pharmaceutical offers products and services including Seirogan and Crebein. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Taiko Pharmaceutical Co., Ltd.
Company details
Taiko Pharmaceutical was established in 1946 in Osaka, Japan, within the pharmaceutical sector. Drugs are produced by the company as its primary operations, focusing on manufacturing activities. The headquarters are located in Osaka, where core functions including production and management are handled. Takashi Shibata is designated as CEO and President, overseeing daily operations and strategic direction. The domain seirogan.co.jp is utilized for online presence.
- Headquarters Osaka, Japan
- Employees 214
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website seirogan.co.jp
- Legal Name Taiko Pharmaceutical Co., Ltd.
- Annual Revenue$40.85 M (USD)1.67as on Dec 31, 2025
- Net Profit$5.89 M (USD)2.78as on Dec 31, 2025
- EBITDA$4.62 M (USD)-18.28as on Dec 31, 2025
- Employee Count214
Products & Services of Taiko Pharmaceutical
Taiko Pharmaceutical offers a comprehensive portfolio of products and services, including Seirogan and Crebein.
Seirogan is used for relief of stomach and diarrhea issues, as marketed through various product lines
Crebein is employed for antiviral and antibacterial purposes, contributing to hygiene management
People of Taiko Pharmaceutical
1 people are tracked at Taiko Pharmaceutical (1 in leadership); the tracked headcount is 214.
| Name | Role | Group |
|---|---|---|
Takashi Shibata | CEO & President | Leadership |
Complete people profiles for Taiko Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Taiko Pharmaceutical
Taiko Pharmaceutical is a publicly listed company on the TSE with ticker symbol 4574 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Mar 2009
- Listed onTSE: 4574
- Listed entityTaiko Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3442200006
- Share price259.00 JPY (-1.52% on the day) · 2026-10-14
- Market capitalisation13,171,346,478.00 JPY
- Price to earnings18.9
- EPS (diluted, trailing year)13.69 JPY
- Dividend yield1.28%
- Volume (last session)85,600
Financials of Taiko Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.40B JPY | 923.0M JPY | 724.0M JPY |
| 2024 | 6.29B JPY | 898.0M JPY | 886.0M JPY |
| 2023 | 6.12B JPY | -3.61B JPY | -302.0M JPY |
| 2022 | 5.04B JPY | -4.89B JPY | -2.34B JPY |
| 2021 | 10.72B JPY | -9.59B JPY | -4.01B JPY |
Detailed financial statements for Taiko Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Taiko Pharmaceutical
The website of Taiko Pharmaceutical (seirogan.co.jp) receives about 198.7K visits a month and ranks #220,107 among all websites worldwide, #7,228 in Biotechnology and Pharmaceuticals.
- Monthly visits198.7K
▼ 12.7% vs previous month
- Unique visitors164.2K
per month
- Global rank#220,107
among all websites
- Category rank#7,228
Health · Biotechnology and Pharmaceuticals
- Bounce rate67%
- Pages per visit1.6
- Average visit37 sec
- DevicesDesktop 23% · Mobile 77%
Websites whose visitors overlap most with Taiko Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| wakamoto-pharm.co.jp | 100% | 203.2K | #227,483 | View details | |
| rtechueno.com | 99% | View details | |||
bio-three.jp | bio-three.jp | 98% | #323,410 | – | |
| canbas.co.jp | 88% | 28.2K | #1,124,423 | View details | |
| kyowayakuhin.co.jp | 88% | 20.6K | #1,143,369 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Taiko Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Taiko Pharmaceutical
Complete news archive for Taiko Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taiko Pharmaceutical
Taiko Pharmaceutical was founded in 1946.
Taiko Pharmaceutical is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Takashi Shibata is the CEO of Taiko Pharmaceutical, as recorded in our data.
Taiko Pharmaceutical has 214 employees.
Annual revenue of Taiko Pharmaceutical is $40.85M as on Dec 31, 2025.
Taiko Pharmaceutical was established in 1946 in Osaka, Japan, within the pharmaceutical sector. Drugs are produced by the company as its primary operations, focusing on manufacturing activities. The headquarters are located in Osaka, where core functions including production and management are handled. Takashi Shibata is designated as CEO and President, overseeing daily operations and strategic direction. The domain seirogan.co.jp is utilized for online presence.
Taiko Pharmaceutical offers Seirogan and Crebein.
Yes, Taiko Pharmaceutical is publicly traded on TSE under the ticker symbol 4574.
Taiko Pharmaceutical operates through Taiko Pharmaceutical Co., Ltd..
The website of Taiko Pharmaceutical receives about 199 thousand visits a month and ranks #220,107 among all websites worldwide.